Nemluvio (nemolizumab-ilto) - Galderma
Dupixent (dupilumab) - Sanofi, Regeneron
Concurrent Nemolizumab plus Dupilumab in Severe Atopic Dermatitis (ACAAI 2026) - Oct 28, 2026 - Abstract #M744; Pres time: Nov 13, 2026; 05:45 PM - 06:00 PM; Location: Phoenix Convention Center • North Halls 4–6 (Lower Level); Monitor 11; No abstract available 
Atopic Dermatitis • Dermatitis • Dermatology • Immunology
https://annualmeeting.acaai.org/2026/submit_abstract.cfm
 
Oct 28, 2026
 
Prev Next